Physiological monitoring in the complex multimorbid heart failure patient - Conclusions.
Adherence
Healthcare systems
Heart failure
Physiology
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
8
1
2020
Statut:
ppublish
Résumé
Comorbidities are increasingly recognized as crucial components of the heart failure syndrome. Main specific challenges are polypharmacy, poor adherence to treatments, psychological aspects, and the need of monitoring after discharge. The chronic multimorbid patient therefore represents a specific heart failure phenotype that needs an appropriate and continuous management over time. This supplement issue covers the key points of a series of meeting coordinated by the Heart Failure Association of the European Society of Cardiology (ESC), that have discussed the issues surrounding the effective monitoring of our ever more complex and multimorbid heart failure patients. Here, we present an overview of the complex issues from a healthcare delivery perspective.
Identifiants
pubmed: 31908622
doi: 10.1093/eurheartj/suz232
pii: suz232
pmc: PMC6937511
doi:
Types de publication
Journal Article
Langues
eng
Pagination
M68-M71Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2019.
Références
Eur J Heart Fail. 2018 Mar;20(3):504-510
pubmed: 29193462
Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):98
pubmed: 28025215
Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):54-63
pubmed: 28633477
Eur J Heart Fail. 2014 Mar;16(3):325-33
pubmed: 24464788
Am J Med. 2011 Feb;124(2):136-43
pubmed: 21295193
Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188
pubmed: 29726985
Eur J Heart Fail. 2019 May;21(5):543-544
pubmed: 31069910
Eur J Heart Fail. 2017 Nov;19(11):1414-1423
pubmed: 28463464
Circ Heart Fail. 2012 Jan;5(1):25-35
pubmed: 21956192
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):183-184
pubmed: 28922837
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):48-57
pubmed: 27530337
Eur J Heart Fail. 2018 Feb;20(2):373-381
pubmed: 29027329
Eur J Heart Fail. 2017 Nov;19(11):1424-1426
pubmed: 28786154
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):1-2
pubmed: 28062653
Eur J Heart Fail. 2017 Dec;19(12):1566-1568
pubmed: 29271591
Eur J Heart Fail. 2017 May;19(5):643-649
pubmed: 28295907
J Card Fail. 2013 May;19(5):317-24
pubmed: 23663814
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Eur J Heart Fail. 2017 Oct;19(10):1216-1217
pubmed: 28990347
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):235-250
pubmed: 28541499
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):1
pubmed: 29315398
Eur Heart J Cardiovasc Pharmacother. 2017 Apr 1;3(2):99
pubmed: 28069608
Am Heart J. 2009 Oct;158(4):644-52
pubmed: 19781426
Eur J Heart Fail. 2017 Mar;19(3):434
pubmed: 28251774
Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):193-194
pubmed: 29982385
Am J Cardiol. 2015 Dec 15;116(12):1890-7
pubmed: 26508709
J Card Fail. 2011 Aug;17(8):664-9
pubmed: 21807328